Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Molecules is a pioneering strategic platform established by Granules India to lead the decarbonization of the pharmaceutical industry. Primarily operated through its subsidiary, Granules CZRO, the platform focuses on the sustainable manufacturing of high-volume active pharmaceutical ingredients (APIs) and key starting materials (KSMs) such as paracetamol and metformin using green hydrogen and renewable energy. The platform's centerpiece is a 100-acre integrated Green Pharmaceutical Zone (GPZ) in Kakinada, Andhra Pradesh, which aims to achieve near-net-zero emissions by integrating green chemistry, biocatalysis, and continuous manufacturing. By eliminating the industry's traditional reliance on fossil-fuel-based energy and feedstocks, Green Molecules is redefining sustainable drug production for global healthcare. The initiative reflects a massive multi-year investment intended to foster circularity and environmental stewardship in the pharmaceutical value chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Molecules.